Founded in 1997, Shandong Kexing Bioproducts integrates R&D, manufacture, and sales of biopharmaceuticals. Genzon Group and Shenzhen Kexing Biotech Co. Ltd are its major stock holders.
Located in Shangdong Mingshui Development Zone in China, its production site offers Recombinant Human Erythropoietin Injection(EPO)、Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)\Filgrastim、and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. Its workshop for genetically engineered drugs has area of 1,500 square meters, and workshop for micro-ecological drugs covers 2,000 square meters. Both workshops have passed China’s GMP certification. The company plans to construct new factory buildings to improve production capacity and meet increasing market demands.
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China’s biopharmaceutical industry after more than 10 years of development.
No.1 Chinese producer of Recombinant Human Erythropoietin Injection（CHO Cell）
One of leading bio-pharmaceutical suppliers in China
EPSINO is the first EPO Product put in Chinese market
The only EPO product free of human albumin in China
First-class G-CSF
Non-toxic certain bacteria combination
Diversity of target markets for treatment of renal disease, tumors, gastrointestinal tract disease
Advanced market- oriented R&D capabilities
Mature domestic marketing network
High-efficient international sales team
Improved market-oriented management team
Strict quality management system to ensure safety,effectiveness and stability
Its marketing and sales team targeting Chinese market consists of professional pharmaceutical sales force working in major Chinese cities. The international sales team includes several specialists. The products have passed GMP audit from different countries and are sole to over 10 countries and regions in South America, Southeast Asia, Africa, Middle East, and East Europe. The international sales team has more than 10 years of experiences of marketing genetic products and international sales. The company has been supplying high-quality and safe bioproducts to all over the world.
Its R&D team consists of specialists with rich experience of technical development, clinical research and application for product approval in research institutes and hospitals. Honesty is our belief. High quality is our fundamentality.
Win-win cooperation is our strategy. To create health is our goal.
Shandong Kexing Bioproducts Co., Ltd. will warmly welcome all the friends home and abroad to visit us.
Located in Shangdong Mingshui Development Zone in China, its production site offers Recombinant Human Erythropoietin Injection(EPO)、Recombinant Human Granulocyte Colony-stimulating Factor Injection(rh-G-CSF)\Filgrastim、and Combined Clostridium Butyricum and Bifidobacterium Powders, Live for clinical and commercial use. Its workshop for genetically engineered drugs has area of 1,500 square meters, and workshop for micro-ecological drugs covers 2,000 square meters. Both workshops have passed China’s GMP certification. The company plans to construct new factory buildings to improve production capacity and meet increasing market demands.
The company develops recombinant genetic biological drugs and micro-ecological preparation, to serve the clinical treatment needs of kidney diseases, tumor, and gastrointestinal diseases. It has become a leading player in China’s biopharmaceutical industry after more than 10 years of development.
No.1 Chinese producer of Recombinant Human Erythropoietin Injection（CHO Cell）
One of leading bio-pharmaceutical suppliers in China
EPSINO is the first EPO Product put in Chinese market
The only EPO product free of human albumin in China
First-class G-CSF
Non-toxic certain bacteria combination
Diversity of target markets for treatment of renal disease, tumors, gastrointestinal tract disease
Advanced market- oriented R&D capabilities
Mature domestic marketing network
High-efficient international sales team
Improved market-oriented management team
Strict quality management system to ensure safety,effectiveness and stability
Its marketing and sales team targeting Chinese market consists of professional pharmaceutical sales force working in major Chinese cities. The international sales team includes several specialists. The products have passed GMP audit from different countries and are sole to over 10 countries and regions in South America, Southeast Asia, Africa, Middle East, and East Europe. The international sales team has more than 10 years of experiences of marketing genetic products and international sales. The company has been supplying high-quality and safe bioproducts to all over the world.
Its R&D team consists of specialists with rich experience of technical development, clinical research and application for product approval in research institutes and hospitals. Honesty is our belief. High quality is our fundamentality.
Win-win cooperation is our strategy. To create health is our goal.
Shandong Kexing Bioproducts Co., Ltd. will warmly welcome all the friends home and abroad to visit us.
